University of California San Francisco

Give to UCSF
Advanced
1321 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics

UCSF Scientists Play Key Role in Success of Yervoy, a New Cancer Drug

<p>Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma –&nbsp;and that is being used to treat other cancers in ongoing clinical trials –&nbsp;is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.</p>

Placeholder image

Men's and Women's Immune Systems Respond Differently to PTSD

Men and women had starkly different immune system responses to chronic post-traumatic stress disorder, with men showing no response and women showing a strong response, in two studies by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

Placeholder image

Lanier's Pursuit of Immune System's Natural Killers Leads to New Treatment

Lewis Lanier, whose studies of cells of the immune system have caused textbooks to be rewritten and opened new avenues for exploring immunotherapies for a range of diseases, offered advice to young researchers during the 54th Faculty Research Lectureship in Basic Science at UCSF.

Placeholder image

UCSF leads Lancet series on malaria elimination

<em>The Lancet</em> launched a special series on malaria elimination Oct. 29, led by the Global Health Group (GHG), a part of UCSF Global Health Sciences. The series included work by 36 authors worldwide, with guidance and support provided by a GHG-convened global advisory group of malaria experts, known as the Malaria Elimination Group.

Placeholder image